Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.
Ciprofloxacin was administered to 12 healthy male volunteers at doses of 300 and 400 mg intravenously (i.v.) and 500 and 750 mg orally in a randomized, double-blind, single-dose, four-period crossover study. On each treatment day, each subject received both oral and i.v. formulations, one of which w...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1992
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188820/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510426/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.5.993 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|